Scarlett has oversight responsibility of Regulatory Affairs and DEA Compliance. With significant pharmaceutical experience, her filing expertise includes numerous ANDAs, NDAs and 505(b)(2) NDAs in multiple dosage forms, including solid oral, liquid, suspensions, semi-solids, and powders. She has managed post-approval changes, electronic submission publishing, ADE reporting and general Regulatory compliance, as well as ensuring compliance with DEA regulations. Scarlett earned her Juris Doctorate degree from St. Louis University. She is a member of the Drug Information Association and Regulatory Affairs Professional Society.